BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12058644)

  • 1. Vaccines against asexual stage malaria parasites.
    Kumar S; Epstein JE; Richie TL
    Chem Immunol; 2002; 80():262-86. PubMed ID: 12058644
    [No Abstract]   [Full Text] [Related]  

  • 2. Nucleic acid vaccines against malaria.
    Doolan DL; Hoffman SL
    Chem Immunol; 2002; 80():308-21. PubMed ID: 12058647
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune responses to liver-stage parasites: implications for vaccine development.
    Hollingdale MR; Krzych U
    Chem Immunol; 2002; 80():97-124. PubMed ID: 12058653
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines. Searching for a parasite's weak spot.
    Taubes G
    Science; 2000 Oct; 290(5491):434-7. PubMed ID: 11183756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sporozoite antigens: biology and immunology of the circumsporozoite protein and thrombospondin-related anonymous protein.
    Sinnis P; Nardin E
    Chem Immunol; 2002; 80():70-96. PubMed ID: 12058652
    [No Abstract]   [Full Text] [Related]  

  • 6. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
    Ballou WR; Kester KE; Heppner DG
    Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
    [No Abstract]   [Full Text] [Related]  

  • 7. Nucleic acid malaria vaccines. Current status and potential.
    Hoffman SL; Doolan DL; Sedegah M; Gramzinski R; Wang H; Gowda K; Hobart P; Margalith M; Norman J; Hedstrom RC
    Ann N Y Acad Sci; 1995 Nov; 772():88-94. PubMed ID: 8546416
    [No Abstract]   [Full Text] [Related]  

  • 8. Malaria vaccine development using synthetic peptides as a technical platform.
    Corradin G; Céspedes N; Verdini A; Kajava AV; Arévalo-Herrera M; Herrera S
    Adv Immunol; 2012; 114():107-49. PubMed ID: 22449780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parasite Recognition and Signaling Mechanisms in Innate Immune Responses to Malaria.
    Gowda DC; Wu X
    Front Immunol; 2018; 9():3006. PubMed ID: 30619355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of protective immunity to malaria.
    Anders RF; Brown GV; Coppel RL; Kemp DJ
    Lepr Rev; 1986 Dec; 57 Suppl 2():245-53. PubMed ID: 3553798
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards a malaria vaccine: what is in sight?
    del Giudice G
    Allergol Immunopathol (Madr); 1991; 19(3):129-35. PubMed ID: 1799171
    [No Abstract]   [Full Text] [Related]  

  • 12. Protection of Aotus monkeys after immunization with recombinant antigens of Plasmodium falciparum.
    Enders B; Hundt E; Knapp B
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():413-22. PubMed ID: 1343721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole parasite vaccines for the asexual blood stages of Plasmodium.
    Good MF; Stanisic DI
    Immunol Rev; 2020 Jan; 293(1):270-282. PubMed ID: 31709558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria DNA vaccines in Aotus monkeys.
    Gramzinski RA; Maris DC; Doolan D; Charoenvit Y; Obaldia N; Rossan R; Sedegah M; Wang R; Hobart P; Margalith M; Hoffman S
    Vaccine; 1997 Jun; 15(8):913-5. PubMed ID: 9234546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically attenuated malaria parasites as vaccines.
    Vaughan AM; Kappe SHI
    Expert Rev Vaccines; 2017 Aug; 16(8):765-767. PubMed ID: 28612631
    [No Abstract]   [Full Text] [Related]  

  • 16. Malaria vaccine design: immunological considerations.
    Good MF; Doolan DL
    Immunity; 2010 Oct; 33(4):555-66. PubMed ID: 21029965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvants and malaria vaccine development.
    Xiao L; Rafi-Janajreh A; Patterson P; Zhou Z; Lal AA
    Chem Immunol; 2002; 80():343-65. PubMed ID: 12058649
    [No Abstract]   [Full Text] [Related]  

  • 18. Malaria vaccine: candidate antigens, mechanisms, constraints and prospects.
    Carvalho LJ; Daniel-Ribeiro CT; Goto H
    Scand J Immunol; 2002 Oct; 56(4):327-43. PubMed ID: 12234254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines.
    Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L
    Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasmodium p25 and p28 surface proteins: potential transmission-blocking vaccines.
    Saxena AK; Wu Y; Garboczi DN
    Eukaryot Cell; 2007 Aug; 6(8):1260-5. PubMed ID: 17557884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.